To evaluate the role of partial cytoreductive surgery in a patient with advanced extramedullary plasmacytoma after all conventional treatment options were exhausted.
Key Findings:
Surgical cytoreduction was performed without periprocedural complications, but the underlying disease progressed, leading to the patient's death.
Interpretation:
Cytoreductive surgery may be a safe and reproducible procedure in specific cases of extramedullary plasmacytoma, but it does not guarantee improved prognosis or survival, highlighting the need for careful patient selection.
Limitations:
The case represents a single patient experience, limiting generalizability.
The advanced stage of the disease may have influenced the outcome.
Lack of long-term follow-up data limits understanding of the surgery's impact.
Conclusion:
While cytoreductive surgery can be considered in select cases of extramedullary plasmacytoma, its effectiveness in improving patient outcomes remains uncertain.
